Overall, there was no association between the XRCC1 Arg399Gln polymorphism and risk of nasopharyngeal cancer, oral cancer, larynx cancer, thyroid cancer, and other head and neck cancer sites. The gene discussed is XRCC1; the disease is nasopharyngeal carcinoma.